No Results Found
Try adjusting your search to find what you’re looking for.
4/15/2025
Attovia Therapeutics Announces $90 Million Series C Financing to Advance ATTOBODY-based Programs through Clinical Proof of Concept
Series C round led by Deep Track Capital with participation from additional new and existing investors; financing will fund early-to-mid-stage clinical studies for ATTO-1310 in chronic pruritus and ATTO-3712 in atopic dermatitis, and multiple earlier-stage multi-specific programs.
Read More
4/10/2025
Spotlight on Remi Dangla, PhD – CEO Stilla Technologies April 2024
Spotlight on Remi Dangla, PhD – CEO Stilla Technologies
Read More
1/29/2025
Spotlight on Yuling Luo, PhD – CEO Alamar Biosciences January 2024
Spotlight on Yuling Luo, PhD – CEO Alamar Biosciences
Read More
1/09/2025
Pattern Bioscience Names Carey-Ann Burnham CEO
Founder and former CEO Nick Arab to transition to CTO and focus on advancing Pattern’s single-cell microbiology technology
Read More
